Industry News

Biotech

• Ra Pharma files $100M round as Soliris rival clears phase 2 trial 2018/12/11
  Armed with a phase 2 win for its lead drug zilucoplan in rare disease myasthenia gravis, Ra Pharma has pressed the button on a public funding round that it hopes could raise up to $115 million.
• Amgen teams with Entera to develop oral biologics 2018/12/11
  Amgen has struck a deal with Entera Bio to develop oral formulations of up to three large molecules. The agreement sees Amgen pay a “modest” upfront fee to access Entera’s technology and commit to up …
• 4 years after mega IPO, Circassia set for small-cap exchange 2018/12/11
  Four years ago, Circassia looked to have ushered in a new era for biotech IPOs on the London Stock Exchange when it raised £200 million ($252 million) to finance development of anti-allergy drugs. Tod …
• MacroGenics halts trials of cancer drug after FDA partial hold 2018/12/10
  Potential liver-related side effects have led to the FDA placing a partial clinical hold on a MacroGenics-developed bispecific antibody for cancer.
• CRISPR-based heart test pinpoints genetic risk for severe cardiomyopathy 2018/12/10
  Severe hypertrophic cardiomyopathy, a dangerous disorder that causes an abnormal thickening of the heart walls, is often associated with a variant in the gene TNNT2. Now, a Penn team has developed a t …

Medical Devices

Error: Feed has an error or is not valid

Pharma

• Merck promotes oncology, vaccine executives to replace Adam Schechter in commercial rejig 2018/12/11
  Merck & Co. boasted some major success in the sales department this year, but the company’s commercial organization will still get a makeover for 2019. Adam Schechter, president of global human he …
• Boehringer Ingelheim chops 295 jobs in France but vows $380M in animal health investments 2018/12/11
  As part of its $12.5 billion asset swap with Sanofi, Boehringer Ingelheim will cut 327 of its 2,800 workers in France and create 32 new jobs. The layoffs are part of BI's bid to turn the French c …
• China's Zhejiang Huahai lambasted in FDA warning letter for putting profits ahead of safety 2018/12/11
  The Chinese API maker at the heart of a global scare and recall of blood pressure medicines has been savaged in an FDA warning letter for failing to uncover a suspected carcinogen in its APIs when a c …
• As competition heats up, U.S. prices for Remicade and biosims slip: analyst 2018/12/11
  As Johnson & Johnson competes with biosimilars to its big-selling Remicade, prices across the category are gradually falling, an analyst says—and Pfizer's Inflectra has taken the biggest tumb …
• GlaxoSmithKline's Shingrix shortage expected to persist 'throughout 2019' 2018/12/10
  GlaxoSmithKline is working to boost its supply of shingles vaccine Shingrix, but in the meantime, a shortage will last until next year.

Vaccines

Error: Feed has an error or is not valid